Los programas informáticos y los cálculos de riesgo del síndrome de Down.

Same author

First-trimester screening for pre-eclampsia: estimated vs measured mean arterial pressure.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022

Same author

A flawed challenge but valid recommendation: a response to Takoudes and Hamar.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2015

Same author

Circulating cell free DNA testing: are some test failures informative?

Prenatal diagnosis·2014

Same author

Inhibin A measurement using an automated assay platform.

Prenatal diagnosis·2008

Same author

The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.

Journal of medical screening·2004

Same author

Cystic fibrosis: selecting the prenatal screening strategy of choice.

Prenatal diagnosis·2003

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Los programas informáticos y los cálculos de riesgo del síndrome de Down.

Videos de Conceptos Relacionados

First-trimester screening for pre-eclampsia: estimated vs measured mean arterial pressure.

A flawed challenge but valid recommendation: a response to Takoudes and Hamar.

Circulating cell free DNA testing: are some test failures informative?

Inhibin A measurement using an automated assay platform.

The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.

Cystic fibrosis: selecting the prenatal screening strategy of choice.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Los programas informáticos y los cálculos de riesgo del síndrome de Down.

Videos de Conceptos Relacionados

Artículos Relacionados

First-trimester screening for pre-eclampsia: estimated vs measured mean arterial pressure.

A flawed challenge but valid recommendation: a response to Takoudes and Hamar.

Circulating cell free DNA testing: are some test failures informative?

Inhibin A measurement using an automated assay platform.

The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.

Cystic fibrosis: selecting the prenatal screening strategy of choice.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.